Charles Schwab’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $164M | Buy |
773,711
+12,921
| +2% | +$2.54M | 0.02% | 538 |
|
|
2026
Q1 | $149M | Buy |
760,790
+9,736
| +1% | +$1.89M | 0.02% | 537 |
|
|
2025
Q4 | $130M | Buy |
751,054
+4,003
| +0.5% | +$729K | 0.02% | 585 |
|
|
2025
Q3 | $142M | Buy |
747,051
+492
| +0.1% | +$87.3K | 0.02% | 528 |
|
|
2025
Q2 | $134M | Buy |
746,559
+5,721
| +0.8% | +$994K | 0.02% | 543 |
|
|
2025
Q1 | $125M | Buy |
740,838
+4,405
| +0.6% | +$724K | 0.02% | 547 |
|
|
2024
Q4 | $111M | Buy |
736,433
+28,333
| +4% | +$4.41M | 0.02% | 606 |
|
|
2024
Q3 | $110M | Buy |
708,100
+12,565
| +2% | +$1.88M | 0.02% | 607 |
|
|
2024
Q2 | $95.2M | Buy |
695,535
+15,210
| +2% | +$2.08M | 0.02% | 672 |
|
|
2024
Q1 | $90.6M | Buy |
680,325
+16,408
| +2% | +$2.13M | 0.02% | 648 |
|
|
2023
Q4 | $91.5M | Buy |
663,917
+17,085
| +3% | +$2.25M | 0.02% | 599 |
|
|
2023
Q3 | $78.8M | Buy |
646,832
+6,221
| +1% | +$829K | 0.02% | 609 |
|
|
2023
Q2 | $90M | Sell |
640,611
-5,610
| -0.9% | -$773K | 0.03% | 560 |
|
|
2023
Q1 | $91.4M | Sell |
646,221
-1,842
| -0.3% | -$264K | 0.03% | 545 |
|
|
2022
Q4 | $101M | Sell |
648,063
-20,901
| -3% | -$3M | 0.03% | 476 |
|
|
2022
Q3 | $82.1M | Buy |
668,964
+23,060
| +4% | +$3.04M | 0.03% | 510 |
|
|
2022
Q2 | $85.9M | Buy |
645,904
+12,777
| +2% | +$1.74M | 0.03% | 511 |
|
|
2022
Q1 | $86.7M | Buy |
633,127
+7,122
| +1% | +$993K | 0.03% | 576 |
|
|
2021
Q4 | $108M | Buy |
626,005
+17,367
| +3% | +$2.64M | 0.03% | 496 |
|
|
2021
Q3 | $88.4M | Sell |
608,638
-22,880
| -4% | -$3.35M | 0.03% | 550 |
|
|
2021
Q2 | $83.3M | Buy |
631,518
+9,795
| +2% | +$1.28M | 0.03% | 587 |
|
|
2021
Q1 | $79.8M | Buy |
621,723
+9,815
| +2% | +$1.21M | 0.03% | 579 |
|
|
2020
Q4 | $72.9M | Buy |
611,908
+3,164
| +0.5% | +$386K | 0.03% | 565 |
|
|
2020
Q3 | $69.7M | Sell |
608,744
-26,301
| -4% | -$3.11M | 0.03% | 480 |
|
|
2020
Q2 | $72.4M | Sell |
635,045
-17,396
| -3% | -$1.85M | 0.04% | 467 |
|
|
2020
Q1 | $52.4M | Buy |
652,441
+3,516
| +0.5% | +$364K | 0.03% | 509 |
|
|
2019
Q4 | $69.3M | Buy |
648,925
+11,300
| +2% | +$1.18M | 0.04% | 462 |
|
|
2019
Q3 | $68.2M | Buy |
637,625
+8,049
| +1% | +$826K | 0.04% | 430 |
|
|
2019
Q2 | $64.1M | Buy |
629,576
+17,950
| +3% | +$1.72M | 0.04% | 454 |
|
|
2019
Q1 | $55M | Buy |
611,626
+15,322
| +3% | +$1.33M | 0.04% | 502 |
|
|
2018
Q4 | $49.7M | Buy |
596,304
+2,416
| +0.4% | +$227K | 0.04% | 453 |
|
|
2018
Q3 | $64.1M | Buy |
593,888
+53,969
| +10% | +$5.92M | 0.04% | 406 |
|
|
2018
Q2 | $59.4M | Buy |
539,919
+10,066
| +2% | +$1.05M | 0.04% | 422 |
|
|
2018
Q1 | $53.1M | Buy |
529,853
+10,873
| +2% | +$1.11M | 0.04% | 447 |
|
|
2017
Q4 | $51.1M | Buy |
518,980
+8,866
| +2% | +$840K | 0.04% | 439 |
|
|
2017
Q3 | $47.8M | Buy |
510,114
+22,798
| +5% | +$2.42M | 0.04% | 435 |
|
|
2017
Q2 | $54.2M | Buy |
487,316
+18,968
| +4% | +$2.01M | 0.05% | 359 |
|
|
2017
Q1 | $46M | Buy |
468,348
+18,337
| +4% | +$1.75M | 0.05% | 392 |
|
|
2016
Q4 | $41.4M | Buy |
450,011
+1,071
| +0.2% | +$92.3K | 0.05% | 386 |
|
|
2016
Q3 | $38M | Buy |
448,940
+3,955
| +0.9% | +$332K | 0.04% | 404 |
|
|
2016
Q2 | $36.2M | Buy |
444,985
+7,619
| +2% | +$580K | 0.05% | 405 |
|
|
2016
Q1 | $31.3M | Sell |
437,366
-98,725
| -18% | -$6.62M | 0.04% | 444 |
|
|
2015
Q4 | $38.1M | Buy |
536,091
+18,751
| +4% | +$1.26M | 0.05% | 349 |
|
|
2015
Q3 | $31.8M | Buy |
517,340
+2,982
| +0.6% | +$208K | 0.05% | 378 |
|
|
2015
Q2 | $37.3M | Buy |
514,358
+5,974
| +1% | +$441K | 0.05% | 362 |
|
|
2015
Q1 | $39.1M | Buy |
508,384
+38,373
| +8% | +$2.75M | 0.05% | 337 |
|
|
2014
Q4 | $31.5M | Buy |
470,011
+31,661
| +7% | +$2M | 0.05% | 375 |
|
|
2014
Q3 | $26.6M | Buy |
438,350
+16,005
| +4% | +$986K | 0.04% | 402 |
|
|
2014
Q2 | $24.8M | Buy |
422,345
+17,074
| +4% | +$1,000K | 0.04% | 413 |
|
|
2014
Q1 | $23.5M | Buy |
405,271
+64,219
| +19% | +$3.44M | 0.04% | 411 |
|
|
2013
Q4 | $18.3M | Buy |
341,052
+6,472
| +2% | +$384K | 0.03% | 458 |
|
|
2013
Q3 | $20.8M | Buy |
334,580
+10,371
| +3% | +$621K | 0.04% | 397 |
|
|
2013
Q2 | $19.6M | Buy |
+324,209
| New | +$19.3M | 0.04% | 385 |
|
Other funds holding DGX
EIG
Charles Schwab's DGX Position: Q2 2026 in Review
Charles Schwab increased its Quest Diagnostics (DGX) stake by 1.7% in Q2 2026, buying an estimated $2.54M and bringing the position to 773,711 shares worth $164M. The position accounts for 0.02% of the portfolio, ranked #538.
Charles Schwab first reported a position in DGX in Q2 2013 and has held it in 53 quarters since. 1,103 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Charles Schwab held 773,711 shares of Quest Diagnostics worth $164M as of Q2 2026.
- Charles Schwab bought 12,921 Quest Diagnostics shares in Q2 2026, an estimated $2.54M.
- Quest Diagnostics made up 0.02% of Charles Schwab's portfolio in Q2 2026, its #538 holding.
- Charles Schwab first reported a position in Quest Diagnostics in Q2 2013 and has held it in 53 quarters since.
- 1,103 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.